Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.